Skip to Main Content

Paper Details

An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies.
Cell Mol Life Sci
1
2022
ACLY, ALK, BRAF, EGFR, IF4B, IF4G1, LIMA1, MET, MET-, EGFR-, ALK- or BRAF (V600)-positive cancer models, MYCN, NCBP1, NSCLC, OAPS, Oncogene, P3C2A, PDXs, TERF2, addicted cell line models, addicting oncogene, cancer, cancer cell samples, cancer cells, ex vivo patient organotypic cultures, oncogene, patient, tumor
Author NameAffiliation
Ruedi AebersoldInstitute of Molecular Systems Biology, ETH Zurich
Ruedi AebersoldUniversity of Zurich
Ruedi AebersoldInstitute of Molecular Systems Biology, ETH Zurich
Ruedi AebersoldUniversity of Zurich
  • 1 - 4

Datasets

Release 1.2